Astellas Pharma Inc (ALPMY)
9.50
+0.03
(+0.32%)
USD |
OTCM |
Apr 19, 16:06
Astellas Pharma Cash from Investing (Quarterly): -155.23M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -155.23M |
| September 30, 2023 | -5.333B |
| June 30, 2023 | -89.64M |
| March 31, 2023 | -187.55M |
| December 31, 2022 | -187.32M |
| September 30, 2022 | -103.15M |
| June 30, 2022 | -147.75M |
| March 31, 2022 | -137.35M |
| December 31, 2021 | 87.84M |
| September 30, 2021 | -313.82M |
| June 30, 2021 | -192.63M |
| March 31, 2021 | -123.98M |
| December 31, 2020 | -287.81M |
| September 30, 2020 | -97.47M |
| June 30, 2020 | -263.27M |
| March 31, 2020 | -2.902B |
| December 31, 2019 | -250.07M |
| September 30, 2019 | -306.78M |
| June 30, 2019 | -127.24M |
| March 31, 2019 | -124.20M |
| December 31, 2018 | -182.71M |
| September 30, 2018 | -92.16M |
| June 30, 2018 | 22.43M |
| March 31, 2018 | -268.48M |
| December 31, 2017 | -175.68M |
| Date | Value |
|---|---|
| September 30, 2017 | -150.88M |
| June 30, 2017 | -504.26M |
| March 31, 2017 | -29.90M |
| December 31, 2016 | -454.28M |
| September 30, 2016 | -133.44M |
| June 30, 2016 | -60.95M |
| March 31, 2016 | -661.56M |
| December 31, 2015 | -508.51M |
| September 30, 2015 | 12.65M |
| June 30, 2015 | -68.01M |
| March 31, 2015 | -231.64M |
| December 31, 2014 | -263.42M |
| September 30, 2014 | -39.66M |
| June 30, 2014 | -118.89M |
| March 31, 2014 | 88.73M |
| December 31, 2013 | -107.73M |
| September 30, 2013 | -111.42M |
| June 30, 2013 | -137.66M |
| March 31, 2011 | -39.18M |
| December 31, 2010 | 236.86M |
| September 30, 2010 | -137.42M |
| June 30, 2010 | -2.878B |
| March 31, 2010 | 85.96M |
| December 31, 2009 | -118.01M |
| September 30, 2009 | -129.94M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.333B
Minimum
Sep 2023
87.84M
Maximum
Dec 2021
-585.20M
Average
-187.32M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Daiichi Sankyo Co Ltd | -3.319B |
| Takeda Pharmaceutical Co Ltd | -460.58M |
| Nxera Pharma Co Ltd | -18.93M |
| PeptiDream Inc | -3.046M |
| Stemcell Holdings Inc | -0.1868M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 340.83M |
| Cash from Financing (Quarterly) | -690.16M |
| Free Cash Flow | 952.05M |
| Free Cash Flow Per Share (Quarterly) | 0.1358 |
| Free Cash Flow to Equity (Quarterly) | 23.46M |
| Free Cash Flow to Firm (Quarterly) | 253.89M |
| Free Cash Flow Yield | 5.55% |